Sotera Health Company (NASDAQ:SHC) Receives Average Recommendation of "Moderate Buy" from Analysts

Key Points

• "Moderate Buy" consensus from 11 analysts (eight buy, three hold) with a 12‑month average target of $20.43.
• Director GTCR Investment XI LLC sold 10,000,000 shares at $15.27 on March 6 for about $152.7M, reducing its stake by ~44% and leaving insiders with 47.55% ownership.
• Sotera topped quarter estimates with $0.26 EPS (vs. $0.24 expected) and $303.44M revenue (vs. $300.68M), and set FY2026 guidance of $0.93–$1.01 EPS while analysts expect 0.61 EPS for the current year.

Sotera Health Company (NASDAQ:SHC - Get Free Report) has been given a consensus rating of "Moderate Buy" by the eleven brokerages that are covering the stock, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The average 12 month target price among analysts that have covered the stock in the last year is $20.4286.

Several research analysts have weighed in on the company. Zacks Research lowered Sotera Health from a "strong-buy" rating to a "hold" rating in a report on Friday, January 30th. Piper Sandler raised Sotera Health from a "neutral" rating to an "overweight" rating and raised their price target for the stock from $17.00 to $24.00 in a research report on Friday, January 9th. Weiss Ratings reiterated a "hold (c-)" rating on shares of Sotera Health in a report on Monday, December 29th. William Blair initiated coverage on Sotera Health in a research report on Thursday, December 18th. They issued an "outperform" rating for the company. Finally, Wells Fargo & Company downgraded shares of Sotera Health to an "overweight" rating in a report on Thursday, January 8th.

Insider Buying and Selling at Sotera Health

In other news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the stock in a transaction on Friday, March 6th. The shares were sold at an average price of $15.27, for a total transaction of $152,700,000.00. Following the completion of the sale, the director owned 12,735,301 shares of the company's stock, valued at $194,468,046.27. This represents a 43.98% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 47.55% of the stock is owned by company insiders.

Hedge Funds Weigh In On Sotera Health

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Arizona State Retirement System lifted its holdings in shares of Sotera Health by 1.4% in the third quarter. Arizona State Retirement System now owns 46,183 shares of the company's stock valued at $726,000 after purchasing an additional 621 shares in the last quarter. PNC Financial Services Group Inc. grew its holdings in shares of Sotera Health by 10.8% during the fourth quarter. PNC Financial Services Group Inc. now owns 7,204 shares of the company's stock worth $127,000 after buying an additional 705 shares in the last quarter. Strs Ohio raised its position in Sotera Health by 17.4% in the 4th quarter. Strs Ohio now owns 4,895 shares of the company's stock valued at $86,000 after buying an additional 727 shares during the last quarter. Federated Hermes Inc. lifted its stake in Sotera Health by 6.0% in the 4th quarter. Federated Hermes Inc. now owns 16,676 shares of the company's stock valued at $294,000 after acquiring an additional 944 shares in the last quarter. Finally, First Citizens Bank & Trust Co. lifted its stake in Sotera Health by 1.5% in the 4th quarter. First Citizens Bank & Trust Co. now owns 66,266 shares of the company's stock valued at $1,169,000 after acquiring an additional 970 shares in the last quarter. 91.03% of the stock is owned by institutional investors and hedge funds.

Sotera Health Stock Up 0.6%

Shares of NASDAQ SHC opened at $14.96 on Friday. Sotera Health has a 52-week low of $9.53 and a 52-week high of $19.85. The company has a debt-to-equity ratio of 3.66, a quick ratio of 2.24 and a current ratio of 2.46. The stock has a market cap of $4.25 billion, a P/E ratio of 55.41 and a beta of 1.88. The firm has a 50 day moving average price of $15.92 and a 200 day moving average price of $16.53.

Sotera Health (NASDAQ:SHC - Get Free Report) last posted its earnings results on Tuesday, February 24th. The company reported $0.26 earnings per share for the quarter, topping the consensus estimate of $0.24 by $0.02. Sotera Health had a net margin of 6.70% and a return on equity of 42.38%. The company had revenue of $303.44 million for the quarter, compared to analyst estimates of $300.68 million. During the same period last year, the business posted $0.21 earnings per share. The business's revenue for the quarter was up 4.6% compared to the same quarter last year. Sotera Health has set its FY 2026 guidance at 0.930-1.01 EPS. Analysts expect that Sotera Health will post 0.61 EPS for the current year.

About Sotera Health

Sotera Health Inc NASDAQ: SHC is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.